Top Markets
Coin of the day
Hyloris Pharmaceuticals S.A. Hyloris Pharmaceuticals S.A.

Hyloris Pharmaceuticals S.A.

HYL
Rank in Stocks #19936
Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and... Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and bringing to market pharmaceutical products designed to fulfill critical unmet medical needs. The company's focus areas include cardiovascular health, oncology, women's health, and other significant therapeutic domains. Its cardiovascular portfolio features treatments for conditions such as atrial fibrillation, acute coronary syndrome, advanced and congestive heart failure, and coronary heart disease. Beyond this, Hyloris addresses a diverse range of other ailments, including post-operative pain management, dental indications, severe and recurring vulvovaginal candidiasis, specific cancers (like acute myeloid leukemia and small cell lung cancer), interstitial cystitis/painful bladder syndrome (IC/PBS), attention deficit hyperactivity disorder (ADHD), and various viral infections. Established in 2012, Hyloris Pharmaceuticals SA is headquartered in Liège, Belgium.
Share Price
$5.22
Last synced: 2026-08-25
Market Cap
$146.14M
Change (1 day)
-1.35%
Change (1 year)
-32.08%
Country
BE
Trade Hyloris Pharmaceuticals S.A. (HYL)

Category

Stock split history for Hyloris Pharmaceuticals S.A. (HYL)
Hyloris Pharmaceuticals S.A. stock (symbol: HYL) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 26, 2026.
One HYL share bought prior to Aug 26, 2026 would equal to 0 HYL shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH